No price history available.
Key financial summary
Financials in EUR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | €m | 20,485 | 23,335 | 29,934 | 27,608 | 27,058 | 26,940 | N/A | N/A |
| Operating profit | €m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | €m | 2,435 | 2,572 | 2,759 | 3,078 | 3,306 | 3,518 | N/A | N/A |
| EPS reported | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | €m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | €m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | €m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in EUR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
L'Air Liquide S.A. is a global entity offering crucial gases, cutting-edge technologies, and a variety of services, primarily serving industrial and healthcare sectors across Europe, the Americas, Asia Pacific, the Middle East, and Africa. The company's extensive operations are organized into three primary divisions: Gas & Services, Engineering & Construction, and Global Markets & Technologies. Within the Gas & Services division, the 'Large Industries' unit supplies essential industrial gases such as oxygen, nitrogen, argon, hydrogen, and carbon monoxide, alongside energy solutions. It also operates cogeneration plants, providing steam and electricity to heavy industries like metals, chemicals, refining, and the energy sector. The 'Industrial Merchant' business line serves a broad range of customers, including those in materials and energy, automotive and manufacturing, food and pharmaceuticals, technology and research, as well as craftsmen and retail, by supplying industrial gases, equipment, hardgoods, and associated services. The healthcare segment provides medical gases, home healthcare support, specialized medical equipment, and unique ingredients to patients, medical professionals, and hospitals. Additionally, the 'Electronics' business delivers carrier gases, advanced electronic specialty materials, equipment, and installation services to the semiconductor, flat panel, and photovoltaic industries. The Engineering & Construction segment is dedicated to the design, development, and construction of industrial gas production facilities for third parties. This division also undertakes the design and manufacturing of plants for traditional, renewable, and alternative energy applications. Lastly, the Global Markets & Technologies segment concentrates on delivering innovative technological solutions—comprising specialized molecules, equipment, and services—to advance energy transition and deep technology initiatives. Its activities include investing in and operating biomethane production units, designing hydrogen refueling stations, and providing gases for challenging offshore environments such as oil and gas platforms, offshore wind turbines, and cryogenic maritime transport. Founded in 1902, L'Air Liquide S.A. is headquartered in Paris, France.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
L'Air Liquide S.A. is a global entity offering crucial gases, cutting-edge technologies, and a variety of services, primarily serving industrial and healthcare sectors across Europe, the Americas, Asia Pacific, the Middle East, and Africa. The company's extensive operations are organized into three primary divisions: Gas & Services, Engineering & Construction, and Global Markets & Technologies. Within the Gas & Services division, the 'Large Industries' unit supplies essential industrial gases such as oxygen, nitrogen, argon, hydrogen, and carbon monoxide, alongside energy solutions. It also operates cogeneration plants, providing steam and electricity to heavy industries like metals, chemicals, refining, and the energy sector. The 'Industrial Merchant' business line serves a broad range of customers, including those in materials and energy, automotive and manufacturing, food and pharmaceuticals, technology and research, as well as craftsmen and retail, by supplying industrial gases, equipment, hardgoods, and associated services. The healthcare segment provides medical gases, home healthcare support, specialized medical equipment, and unique ingredients to patients, medical professionals, and hospitals. Additionally, the 'Electronics' business delivers carrier gases, advanced electronic specialty materials, equipment, and installation services to the semiconductor, flat panel, and photovoltaic industries. The Engineering & Construction segment is dedicated to the design, development, and construction of industrial gas production facilities for third parties. This division also undertakes the design and manufacturing of plants for traditional, renewable, and alternative energy applications. Lastly, the Global Markets & Technologies segment concentrates on delivering innovative technological solutions—comprising specialized molecules, equipment, and services—to advance energy transition and deep technology initiatives. Its activities include investing in and operating biomethane production units, designing hydrogen refueling stations, and providing gases for challenging offshore environments such as oil and gas platforms, offshore wind turbines, and cryogenic maritime transport. Founded in 1902, L'Air Liquide S.A. is headquartered in Paris, France.
